Prenatal diagnosis · 2026
Intrauterine Transfusions in Fetuses Affected by Parvovirus B19: Complications, Challenges and Outcomes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Özbakir Banu, Van den Eede Emma, Nørgaard Lone N, Devlieger Roland, Sundberg Karin, Haak Monique C, Slaghekke Femke
Аннотация
OBJECTIVE: This study evaluates the procedural characteristics, complications, and outcomes of intrauterine transfusion (IUT) for fetal anemia caused by parvovirus B19 infection during the 2023-2024 epidemic in Northwestern Europe.
METHOD: This multicenter observational study included all fetuses undergoing IUT for proven parvovirus B19-induced anemia at three tertiary fetal therapy centers in Northwestern Europe. Maternal, fetal, and procedural data were collected from electronic records. Technical challenges and complications were defined a priori. Primary outcomes were procedural characteristics and complications, prenatal neurological outcomes, and perinatal outcomes.
RESULTS: A total of 93 IUTs were performed in 74 fetuses. Hydrops fetalis was present in 53%. Technical challenges occurred in 24% of procedures and complications in 18%. 59% of technical challenges and 65% of complications occurred in IUTs performed in hydropic fetuses. Intracranial hemorrhage (ICH) occurred in 10% of fetuses and was associated with lower preoperative hemoglobin (2.3 ± 0.6 g/dL vs. 4.4 ± 2.2 g/dL; p = 0.006). Perinatal survival was significantly lower following IUTs with complications (64%) compared with uncomplicated procedures (91%; p = 0.013).
CONCLUSIONS: IUT for parvovirus B19-related fetal anemia is technically demanding, with complication rates exceeding prior reports. Complications and challenges significantly reduce perinatal survival. These findings underscore the importance of centralizing care in high-volume fetal medicine centers with experienced operators.
METHOD: This multicenter observational study included all fetuses undergoing IUT for proven parvovirus B19-induced anemia at three tertiary fetal therapy centers in Northwestern Europe. Maternal, fetal, and procedural data were collected from electronic records. Technical challenges and complications were defined a priori. Primary outcomes were procedural characteristics and complications, prenatal neurological outcomes, and perinatal outcomes.
RESULTS: A total of 93 IUTs were performed in 74 fetuses. Hydrops fetalis was present in 53%. Technical challenges occurred in 24% of procedures and complications in 18%. 59% of technical challenges and 65% of complications occurred in IUTs performed in hydropic fetuses. Intracranial hemorrhage (ICH) occurred in 10% of fetuses and was associated with lower preoperative hemoglobin (2.3 ± 0.6 g/dL vs. 4.4 ± 2.2 g/dL; p = 0.006). Perinatal survival was significantly lower following IUTs with complications (64%) compared with uncomplicated procedures (91%; p = 0.013).
CONCLUSIONS: IUT for parvovirus B19-related fetal anemia is technically demanding, with complication rates exceeding prior reports. Complications and challenges significantly reduce perinatal survival. These findings underscore the importance of centralizing care in high-volume fetal medicine centers with experienced operators.